Identification of bioactive molecules from
Bioactive molecules
COVID-19
Molecular docking
Molecular dynamics simulation
SARS-CoV-2
Triphala
Journal
Journal of King Saud University. Science
ISSN: 2213-686X
Titre abrégé: J King Saud Univ Sci
Pays: Saudi Arabia
ID NLM: 9886378
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
04
10
2021
revised:
20
12
2021
accepted:
05
01
2022
pubmed:
18
1
2022
medline:
18
1
2022
entrez:
17
1
2022
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus disease (SARS-CoV-2) induced coronavirus disease 2019 (COVID-19) pandemic is the present worldwide health emergency. The global scientific community faces a significant challenge in developing targeted therapies to combat the SARS-CoV-2 infection. Computational approaches have been critical for identifying potential SARS-CoV-2 inhibitors in the face of limited resources and in this time of crisis. Main protease (M
Identifiants
pubmed: 35035181
doi: 10.1016/j.jksus.2022.101826
pii: S1018-3647(22)00007-6
pmc: PMC8744360
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101826Informations de copyright
© 2022 The Author(s).
Références
J Genet Eng Biotechnol. 2020 Nov 3;18(1):69
pubmed: 33141358
Nat Prod Res. 2007 Jul 20;21(9):775-81
pubmed: 17763100
Saudi J Biol Sci. 2022 Apr;29(4):2432-2446
pubmed: 34924801
J Chem Inf Model. 2014 Dec 22;54(12):3259-67
pubmed: 25420000
BioTechnologia (Pozn). 2021 Sep 30;102(3):257-275
pubmed: 36606151
J Biomol Struct Dyn. 2022;40(20):10437-10453
pubmed: 34182889
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Front Pharmacol. 2020 Sep 25;11:561334
pubmed: 33101023
J Mol Biol. 2005 Nov 18;354(1):25-40
pubmed: 16242152
PLoS Biol. 2005 Oct;3(10):e324
pubmed: 16128623
Arch Med Sci. 2020 Apr 17;16(3):508-518
pubmed: 32399096
Drug Res (Stuttg). 2020 Sep;70(9):389-400
pubmed: 32746481
J Chem Inf Model. 2010 May 24;50(5):822-39
pubmed: 20423098
Am J Cancer Res. 2020 Dec 01;10(12):4538-4546
pubmed: 33415017
Mol Divers. 2021 Aug;25(3):1963-1977
pubmed: 33856591
Data Brief. 2021 Jun;36:107049
pubmed: 33869690
J Tradit Complement Med. 2022 Jan;12(1):35-43
pubmed: 34099976
Front Pharmacol. 2021 Apr 30;12:628198
pubmed: 33995026
Biochem Biophys Rep. 2021 Sep;27:101032
pubmed: 34099985
Beni Suef Univ J Basic Appl Sci. 2021;10(1):60
pubmed: 34642633
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Interdiscip Toxicol. 2018 May;11(1):5-12
pubmed: 30181707
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
J Virol. 2004 Dec;78(24):13600-12
pubmed: 15564471
Bioorg Med Chem Lett. 2021 Jun 1;41:128029
pubmed: 33839254
Antioxidants (Basel). 2020 Jan 13;9(1):
pubmed: 31941067
Life (Basel). 2021 Apr 06;11(4):
pubmed: 33917319
Pharm Res. 2014 Apr;31(4):1002-14
pubmed: 24306326
Med Chem. 2020;16(7):928-937
pubmed: 31385774
Pharm Res. 2008 Jan;25(1):87-103
pubmed: 17985216
J Biomol Struct Dyn. 2021 Jul;39(10):3449-3458
pubmed: 32397940
Evid Based Complement Alternat Med. 2019 Nov 15;2019:8623909
pubmed: 31885669
Comput Biol Med. 2021 Apr;131:104295
pubmed: 33662683
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874
pubmed: 30768902
J Med Chem. 2016 May 12;59(9):4035-61
pubmed: 26807648
RSC Adv. 2021 Jul 2;11(38):23450-23458
pubmed: 35479789
J Altern Complement Med. 2017 Aug;23(8):607-614
pubmed: 28696777
Food Chem. 2021 Jun 1;346:128933
pubmed: 33418408
J Chem Inf Model. 2014 Apr 28;54(4):1061-9
pubmed: 24735213
Front Pharmacol. 2021 Mar 02;11:578970
pubmed: 33737875
Front Mol Biosci. 2021 May 26;8:625391
pubmed: 34124140
Chin Med. 2018 Jul 18;13:39
pubmed: 30034512
Saudi J Biol Sci. 2022 Feb;29(2):998-1005
pubmed: 35197769
Front Pharmacol. 2020 Oct 08;11:561248
pubmed: 33132909
J Chem Inf Model. 2014 Jul 28;54(7):1951-62
pubmed: 24850022
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1159-1173
pubmed: 28870093
Nucleic Acids Res. 2018 Jul 2;46(W1):W257-W263
pubmed: 29718510
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
Medchemcomm. 2018 Nov 30;10(1):148-157
pubmed: 30774861